Key result
DDX3 depletion reduces Hepatitis E virus replication, revealing an ATPase-dependent pro-viral role.
Why the study?
DDX3 assists or restricts the replication of several viruses, but its role in the replication of hepatitis E virus was unknown.
DDX3 plays a pro-viral role in HEV replication through interaction with the viral capsid protein and requires its ATPase activity.
May guide host-targeted HEV antivirals; leaves open translation from animal models to patients.
DDX3 is an ATP-dependent RNA helicase that is involved in multiple cellular activities, including RNA metabolism and innate immunity. DDX3 is known to assist the replication of some viruses while restricting others through its direct interaction with viral proteins. However, the role of DDX3 in the replication of the hepatitis E virus (HEV) is unknown. In this study, DDX3 was shown to interact with the HEV capsid protein and provide an important role in HEV replication. The DDX3 C-terminal domain was demonstrated to interact with the capsid protein. The depletion of DDX3 led to a significant reduction in HEV replication. Also, the ATPase motif of DDX3 was shown to be required in HEV replication as an ATPase-null mutant DDX3 failed to rescue the viral replication in the DDX3-depleted cells. These results demonstrate a pro-viral role of DDX3 in HEV replication, providing further insights on the virus-cell interactions.
No takes yet. Share an insight, caveat, or question.
Lin et al. (2025) studied Hepatitis E Virus (HEV) infection. DDX3 depletion vs. Control cells was evaluated on HEV replication. Depletion of the RNA helicase DDX3 led to a significant reduction in Hepatitis E virus replication, demonstrating a pro-viral role that requires its ATPase motif.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: